-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amylin Agonist Long Acting in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amylin Agonist Long Acting in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amylin Agonist Long Acting in Obesity Drug Details: Amylin...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Photobac in Gliosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Photobac in Gliosarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Photobac in GliosarcomaDrug Details:Photobac is under development for the treatment of recurrent glioblastoma multiforme,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nifurtimox in Refractory Medulloblastoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Nifurtimox in Refractory MedulloblastomaDrug Details:Nifurtimox is a nitrofuran derivative, acts as an antiprotozoal agent. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DO-1 in GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DO-1 in GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DO-1 in GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)Drug Details:DO-1...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-932 in Generalized Anxiety Disorder (GAD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBV-932 in Generalized Anxiety Disorder (GAD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-932 in Generalized Anxiety Disorder (GAD) Drug Details: ABBV-932...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ASN-004 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ASN-004 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ASN-004 in Colorectal Cancer Drug Details: ASN-004 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nitazoxanide CR in Rhinovirus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Nitazoxanide CR in Rhinovirus InfectionsDrug Details: Nitazoxanide is under development for the treatment of coronavirus disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBV-368 in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABBV-368 in Triple-Negative Breast Cancer (TNBC) Drug Details: ABBV-368 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XmAb-968 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XmAb-968 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.XmAb-968 in Relapsed Acute Myeloid Leukemia Drug Details:XmAb-698 (AMG-424) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozempic in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ozempic in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ozempic in Non-Alcoholic Steatohepatitis (NASH) Drug Details: Semaglutide (Ozempic / NN-9535...